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VI.

Executive Summary
Diagnosing an ischemic stroke accurately and quickly is essential for appropriate treatment and
results in more effective management of the stroke, leading to better patient outcomes. Specifically,
the determination of ischemic versus hemorrhagic stroke leads to critically different treatment
paths, which would be potentially fatal if administered incorrectly. Currently, ischemic strokes are
diagnosed through a series of tests, including a physical examination, CT scans, and a panel of blood
tests to exclude hemorrhagic stroke or other similarly presenting conditions, in order to administer
tPA (the main treatment) within the three hour window.
The discovery of biomarkers, molecules which are upregulated during the onset of a specific
condition or disease, can be used to diagnose patients when integrated with an appropriate
platform. The objective of this thesis was to further develop a paper-based microfluidic device for
the rapid detection of ischemic stroke using biomarkers that can be detected in the blood. This device
uses HRP-based enzyme linked immunosorbent assay (ELISA) technology on a cellulose paper surface
to yield a sensitive (11.8 pM) assay targeting S100B, a protein released by glial cells in the brain during
stroke. Wax printing allows for creation of precise hydrophilic pathways in which sample fluid can
travel within the 3D microfluidic device to react with a variety of proteins and reagents.
This technology has the potential to be implemented globally as a point-of-care device for use in
developing countries without consistent or reliable access to advanced diagnostic technology. The
device is cheap to produce, portable, and results can be determined quickly and qualitatively
analyzed using cell phone images, making it an accessible technology for patients around the globe.

VII.

Major Accomplishments
(1) Designed a device to route fluid on a 3D cellulose- and nitrocellulose-based platform using wax
printing techniques to form hydrophobic barriers, thereby creating hydrophilic channels of paper
in which the sample fluid would travel. The layers of the device can be seen in Figure 1. The
various designs were characterized and tested originally using red dye in order to gain a
fundamental understanding of the device functionality. A housing was designed for the device
and laser cut out of acrylic at the Cal Poly Mustang ‘60 Machine Shop in order to further improve
layer connectivity and ease-of-use for the end user, as seen in Figure 2.
(2) Demonstrated ELISA-like capability of the device using on-board reagents incorporated onto the
paper surface in order to react with and bind to the target analyte and produce a visible
colorimetric response for a positive test, as seen in Figure 3. Used proteins and reagents
purchased using Baker Koob Endowment funds as outlined below in Section VIII to fully display
device functionality to detect the target protein in a sample.
(3) Used smart phone images of the device and computer software to analyze and quantify the
concentration of target analyte in the sample. ImageJ was used to quantify the color intensity in
order to develop a sigmoidal curve for signal-to-noise versus protein concentration. This was then
used to calculate a limit of detection for the device which allows for the determination of clinical
significance of the device. An LOD of 147.9 pg/ml (11.83 pM) was achieved.
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Figure 1. Individual paper layers of the device printed with wax and cut out for assembly. (A) Cellulose
paper layers, from top left: sample introduction pad, wash layer, fluid routing layer, absorbent pad.
(B) Nitrocellulose layer for detection and control regions. (C) Glass fiber pads for storage of the
conjugate antibody.
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Figure 2. Completed device made from acrylic and wax-printed paper layers. (A) Device housing with
screws inserted used to hold top and bottom layers together. (B) Fully assembled device aligned to
accept sample in sample ports.
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Figure 3. Final results of a device running a series of protein concentrations which were analyzed and
plotted versus color intensity. (A) The device run with high protein concentrations and one control,
displaying the blue color for a positive result which can be correlated to concentration. (B) Dose
response graph for a range of concentrations. Error bars = ± 1 SD. Logarithmic (base 10) scale used on
X-axis.

VIII. Expenditure of Funds
The entirety of the funding was used to purchase reagents and proteins that were used to realize
the full ELISA-like functionality of the device to test for a target protein and display a colorimetric
response. Without these funds, the device would only have been validated to the point of fluid
connectivity, and the funding allowed the project to advance to a clinically significant result,
meeting and exceeded the original goals of the project.

IX.

Impact on Student Learning
This thesis allowed me to gain a hands-on and personal realization of how impactful POC diagnostic
development is and how important the field is for healthcare in general. I was able to integrate
what I had learned from my engineering experience on device development, design, and

manufacturing in conjunction with my understanding of biology and immunologic reactions in
order to produce a functioning device. It was extremely impactful for me to have the ability to use
the proteins and reagents purchased with the Baker Koob Endowment funds to create a device
which could be used to detect and diagnose ischemic strokes faster than ever before. I gained
valuable experience in experimental design and implementation, data analysis, and, most
importantly, learning how to overcome obstacles and problem solve to ultimately yield a significant
final result. I have taken this experience and all that I learned to my new position at a POC
diagnostic device company where I will further continue my work in assay development.

